9
Views
19
CrossRef citations to date
0
Altmetric
Original Article

Autoreactive Cytotoxic T Lymphocytes in Pemphigus and Pemphigoid

, , , , &
Pages 247-260 | Received 15 Nov 1988, Published online: 07 Jul 2009

References

  • Anhalt G J, Labib R S, Voorhees J J, Beals T F, Diaz L A. Induction of pemphigus in neonatal mice by passive transfer of IgG from patients with the disease. New Engl J Med 1982; 306: 1189–1196
  • Schiltz J R, Michel B, Papay R. Appearance of “pemphigus acantholysis factor” in human skin culture: A proposed mechanism for pemphigus acantholysis. J Clin Invest 1978; 73: 575–581
  • Kawana S, Geoghegan W D, Jordon R E. Complement fixation by pemphigus antibody. II. Complement enhanced detachement of epidermal cells. Clin Exp Immunol 1985; 61: 517–525
  • Naito K, Morioka S, Ogawa H. Experimental bullous pemphigoid in guinea pigs: the role of pemphigoid antibodies, complement and migrating cells. J Invest Dermatol 1984; 82: 227–230
  • Mitsuhashi Y, Takahashi M-a, Kiuchi H, Mikami H, Hashimoto I, Katabira Y. Induction of pemphigoid lesions in neonatal mice. J Dermatol 1986; 13: 259–265
  • Dubertret L, Betraux B, Fosse M, Fouraine R. Cellular events leading to blister formation in bullous pemphigoid. Br J Dermatol 1980; 104: 615–624
  • Center D M, Wintroub B U, Austen K F. Identification of chemoattractant activity for lymphocytes in blister fluids of patients with bullous pemphigoid: evidence for the presence of a lymphokine. J Invest Dermatol 1983; 81: 204–208
  • Iwatsuki K, Tagami H, Yamada M. Induction of leukocyte adherence at the basement membrane zone with subsequent activation of their metabolic pathway by pemphigoid antibodies and complement. Acta Derm Venereol 1983; 63: 290–295
  • Drijkoningen M, De Wolf-Peeters C, Van Den O, Ord J J, Degreef H, Desmet V. Expression of HLA-DR and T6 antigens on keratinocytes and dendritic cells. A comparative immunohistochemical study. Arch Pathol Lab Med 1986; 110: 321–325
  • Nestor M S, Cochran A J, Ahmed A R. Mononuclear cell infiltrates in bullous disease. J Invest Dermatol 1987; 88: 172–175
  • Redelman D, Hudig D. The mechanism of cell mediated cytotoxicity. Killing by murine cytotoxic T lymphocytes require cell surface thiols and activated proteases. J Immunol 1980; 124: 870–878
  • Hashimoto K, Shafran K M, Webber P S, Lazarus G S, Singer K H. Anti-cell surface pemphigus autoantibody stimulates plasminogen activator activity of human epidermal cells. A mechanism for the loss of epidermal cohesion and blister formation. J Exp Med 1983; 157: 259–272
  • Morioka S, Jensen P J, Lazarus G S. The role of plasminogen and plasminogen activator in acantholysis in vitro (abstr.). J Invest Dermatol 1984; 82: 399
  • Mogovero H S, Jr., Meier H S, Newball H H. Enzymatic activity in bullous pemphigoid blister fluid. Clin Res 1982; 30: 598A
  • Jordon R E. Pemphigus. Dermatology in General Medicine, T B Fitzpatrick, A Z Eisen, K Wolff, I M Freedberg, K F Austen. McGraw-Hill Book Company, New York 1979; 310–317
  • Jordon R E. Bullous pemphigoid, cicatrical pemphigoid, and chronic bullous dermatosis of childhood. Dermatology in General Medicine, T B Fitzpatrick, A Z Eisen, K Wolff, I M Freedberg, K F Austen. McGraw-Hill Book Company, New York 1979; 318–323
  • Böyum A. Isolation of mononuclear cells and granulocytes from human blood. Scand J Clin Lab Invest 1968; 21: 77–89, (Suppl 97)
  • Julius M H, Simpson E, Herzenberg L A. A rapid method for the isolation of functional thymus-derived murine lymphocytes. Eur J Immunol 1973; 3: 645–649
  • Skerrow C J, Skerrow D. A surway of methods of the isolation and fractionation of epidermal tissue and cells. Methods in Skin Research, D Skerrow, C J Skerrow. John Wiley & Sons, Chichester 1985; 609–650
  • Brysk M M, Snider J M, Smith E B. Separation of newborn rat epidermal cells on discontinuous isokinetic gradients of PERCOLL. J Invest Dermatol 1981; 77: 205–209
  • Gray G M, King I A, Yardley H J. The plasma membranes Malpighian cells from pig epidermis: isolation and lipid and protein composition. Brit J Dermatol 1980; 103: 505–515
  • Stanley J R, Koulu L, Thivolet C. Distinction between epidermal antigens binding pemphigus vulgaris and pemphigus foliaceus autoantibodies. J Clin Invest 1984; 74: 313–320
  • Stanley J R, Hawley-Nelson P, Yuspa S H, Shevach E M, Katz S I. Characterization of bullous pemphigoid antigen: a unique basement membrane protein of stratified squamous epithelia. Cell 1981; 24: 897–904
  • Diaz L A, Patel H, Calvanico N J. Isolation of pemphigus antigen from human saliva. J Immunol 1980; 124: 760–765
  • Blann A D. An assay for estimating the cytotoxicity of synovial fluid from patients with rheumatoid arthritis. Scand J Clin Lab Invest 1985; 45: 665–667
  • Grando S A, Drannik G N, Kostromin A P, Glukhenky B T, Boiko Yu Ya, Korostash T A, Demidov S V, Senyuk O F. Assays of serine proteinase esterolytic activity for observation of cytotoxic reactions. J Immunol Meth 1988; 113: 237–246
  • Schert G W, Takenaka Y. A spectrophotometric determination of trypsin and chymotrypsin. Biochim Biophys Acta 1955; 16: 570–575
  • Brunner K T, Engers H D, Cerottini J C. The 51Cr release assay as used for the quantitative measurement of cell-mediated cytolysis in vitro. In vitro Methods in Cell Mediated and Tumor Immunology, B R Bloom, J R David. Academic Press, New York 1976; 423–428
  • Coffey R G. Assays for cyclic nucleotides including clinical application. Immunopharmacology, J W Hadden, R G Coffey, F Spreafico. Plenum, New York 1977; 389–412
  • Steiner A L, Parker G W, Kipnis D M. Radioimmunoassay for cyclic nucleotides. I. Preparations of antibodies and iodinated cyclic nucleotides. J Biol Chem 1972; 247: 1106–1113
  • Gershenfeld H K, Weissman I L. Cloning of a cDNA for a T cell-specific serine protease from a cytotoxic T lymphocyte. Science 1986; 232: 854–858
  • Pasternack M S, Verret C R, Liu M A, Eisen H N. Serine esterase in cytolytic T lymphocytes. Nature 1986; 322: 740–743
  • Roder J C, Argov S, Klein M, Petersson C, Kiessling R, Andersson K, Hansson M. Target-cell interaction in the natural killer system. V. Energy requirements, membrane integrity, and the possible involvement of lysosomal enzymes. Immunology 1980; 40: 107–111
  • Tirosh R., Berke G. T-lymphocyte-mediated cytolysis as an excitatory process of the target. I. Evidence that the target cell may be the site of Ca2+ action. Cell Immunol 1985; 95: 113–123
  • Parker C W. Role of cyclic nucleotides in regulating lymphocytes. Ann N Y Acad Sci 1979; 332: 255–261
  • Hadden J W. Cyclic nucleotides in lymphocyte proliferation and differentiation. Immunopharmacology, J W Hadden, R G Coffey, F Spreafico. Plenum, New York 1977; 1–28
  • Wood G W, Beutner E H. Blocking-immunofluorescence studies on the specificity of pemphigus autoantibodies. Clin Immunol Immunopathol 1977; 7: 168–175
  • Stanley J R, Yaar M, Hawley-Nelson P, Katz S I. Pemphigus antibodies identify a cell surface glycoprotein synthesized by human and mouse keratinocytes. J Clin Invest 1982; 70: 281–288
  • Zhu J., X-Bystryn J-C. Heterogeneity of pemphigoid antigens. J Invest Dermatol 1983; 80: 16–20
  • Grando S A, Glukhenky B T, Romanenko A B. Endogenous proteinases and their inhibitors in the pathogenesis of pemphigus vulgaris. Vestnik Dermatol Venereal 1987; 8: 4–7, (in Russian)
  • Grando S A, Glukhenky B T, Drannik G N, Kostromin A P. Contribution of cellular immune reactions to the pathogenesis of pemphigus vulgaris. Vestnik Dermatol Venereol 1988; 5: 14–19, (in Russian)
  • Grando S A, Glukhenky B T, Romanenko A B, Chayun O A, Dolya S V. The mechanisms of the therapeutic action of extracorporeal detoxication in autoimmune bullous dermatoses. Vestnik Dermatol Venereol 1988; 7: 6–11, (in Russian)
  • Grando S A, Glukhenky B T, Kutsenko N S, Kostromin A P, Demidov S V. Immunopathological aspects of autoimmune bullous dermatoses. Vracheb Delo 1987; 9: 94–97, (in Russian)
  • Birkedal-Hansen H, Taylor R E. Production of three plasminogen activators and an inhibitor in keratinocyte culture. Biochim Biophys Acta 1983; 756: 308–318
  • Isserhoff R R, Rifkin D B. Plasminogen is present in the basal layer of the epidermis. J Invest Dermatol 1983; 80: 297–299
  • Brown J M, Chambers D A. Effect of biological response modifiers on plasminogen activator activity in epidermal cell culture. Br J Dermatol 1984; 111: 252–256, (Suppl 27)
  • Patel H P, Diaz L A, Anhalt G J, Labib R S, Takahashi Y. Demonstration of pemphigus antibodies on the cell surface of murine epidermal cell monolayers and their internalization. J Invest Dermatol 1984; 83: 409–415
  • Mutasim D F, Takahashi Y, Labib R S, Anhalt G J, Patel H P, Diaz L A. A pool of bullous antigen(s) is intracellular and associated with the basal cell cytoskeleton-hemidesmosome complex. J Invest Dermatol 1985; 84: 47–53
  • Regnier M, Vaigot P, Michel S, Prunieras M. Localization of bullous pemphigoid antigen in isolated human keratinocytes. J Invest Dermatol 1985; 85: 187–190
  • Bhogal B, Wojnarowska F, Black M M, Xu W, Levene G M. The distribution of immunoglobulins and the C3 component of complement in multiple biopsies from the uninvolved and perilesional skin in pemphigus. Clin Exp Dermatol 1986; 11: 49–53
  • Lever W F. Pemphigus and pemphigoid: a review of the advances made since 1964. J Am Acad Dermatol 1979; 1: 2–31
  • Grando S A, Glukhenky B T, Sokolov O A, Korostach T A, Chernyavsky A I. Antibodies of pemphigus foliaceus patients capable of specific binding with shedding snake epidermal antigen. Med Sci Res 1988; 16: 165–166
  • Diaz L A, Weiss H J, Calvanico N J. Phylogenetic studies with pemphigus and pemphigoid antibodies. Acta Derm Venereol 1978; 58: 537–540
  • Jordon R E, Kawana S, Fritz K A. Immunopathologic mechanisms in pemphigus and bullous pemphigoid. J Invest Dermatol 1985; 85: 72s–78s

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.